858 related articles for article (PubMed ID: 15832750)
41. [A case of bleeding giant gastrointestinal stromal tumor of the stomach who achieved partial response by chemotherapy].
Takeuchi N; Nishida Y; Nomura Y; Makino T; Maeda T; Iida M; Otsuka A; Tada H; Nakamura T; Ichihara K
Gan To Kagaku Ryoho; 2012 Feb; 39(2):281-4. PubMed ID: 22333644
[TBL] [Abstract][Full Text] [Related]
42. [Gastric stromal tumor. Case report].
Moldovanu R; Lupaşcu C; Moldovanu CM; Dimofte G; Tuţuianu B; Târcoveanu E; Crumpei F; Ferariu D; Cozma L; Vasilescu A; Filip V; Vlad N
Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):372-6. PubMed ID: 17802947
[TBL] [Abstract][Full Text] [Related]
43. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations.
Haller F; Detken S; Schulten HJ; Happel N; Gunawan B; Kuhlgatz J; Füzesi L
Ann Surg Oncol; 2007 Feb; 14(2):526-32. PubMed ID: 17139461
[TBL] [Abstract][Full Text] [Related]
44. A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec(®)) in Mali.
Diallo DA; Ly M; Diallo G; Dembélé AK; Touré M; Touré BA; Koné A; Sidibé S; Dembelé M; Traore BC
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):675-7. PubMed ID: 21641899
[TBL] [Abstract][Full Text] [Related]
45. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients].
Bar-Sela G; Lev LM; Kuten A; Wollner M; Haim N
Harefuah; 2006 Jan; 145(1):2-7, 80. PubMed ID: 16450715
[TBL] [Abstract][Full Text] [Related]
46. [Gastrointestinal stromal tumors (GIST)].
Reichardt P; Pink D; Mrozek A; Lindner T; Hohenberger P
Z Gastroenterol; 2004 Apr; 42(4):327-31. PubMed ID: 15095124
[TBL] [Abstract][Full Text] [Related]
47. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
Papaxoinis G; Nikolaou M; Lianos E; Gaglia A; Economopoulos T; Pectasides D
Anticancer Res; 2006; 26(6C):4869-72. PubMed ID: 17214353
[TBL] [Abstract][Full Text] [Related]
48. Pathology of gastrointestinal stromal tumors.
Hirota S; Isozaki K
Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
[TBL] [Abstract][Full Text] [Related]
49. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
[TBL] [Abstract][Full Text] [Related]
50. [A patient with metastatic gastrointestinal stromal tumor who responded to STI571].
Terashima M; Abe K; Takeda Y; Saito K; Uesugi N; Kato K; Sato K; Maekawa T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):607-10. PubMed ID: 11977548
[TBL] [Abstract][Full Text] [Related]
51. [Gastrointestinal stromal tumors: case reports and review of the literature].
Bronzino P; Colombini M; Ferro A; Gambetta G; Gennaro M; Ivaldi L; Revetria P
G Chir; 2008; 29(1-2):33-7. PubMed ID: 18252146
[TBL] [Abstract][Full Text] [Related]
52. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
Herawi M; Montgomery EA; Epstein JI
Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
[TBL] [Abstract][Full Text] [Related]
53. Biology, diagnosis and therapeutic options in gastrointestinal stromal tumours.
Comandone A; Boglione A
Minerva Chir; 2005 Aug; 60(4):197-203. PubMed ID: 16166919
[TBL] [Abstract][Full Text] [Related]
54. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
Benjamin RS; Blanke CD; Blay JY; Bonvalot S; Eisenberg B
Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
[TBL] [Abstract][Full Text] [Related]
55. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
[TBL] [Abstract][Full Text] [Related]
56. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
Heinrich MC; Corless CL
J Surg Oncol; 2005 Jun; 90(3):195-207; discussion 207. PubMed ID: 15895440
[TBL] [Abstract][Full Text] [Related]
57. Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
Griffin JM; Amand MS; Demetri GD
Clin J Oncol Nurs; 2005 Apr; 9(2):161-9. PubMed ID: 15853160
[TBL] [Abstract][Full Text] [Related]
58. Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment.
Sleijfer S; Wiemer E; Verweij J
Nat Clin Pract Oncol; 2008 Feb; 5(2):102-11. PubMed ID: 18235442
[TBL] [Abstract][Full Text] [Related]
59. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
60. [Successful resection of a gastrointestinal stromal tumor in the pelvis with imatinib mesylate as neoadjuvant therapy].
Nakajima N; Kato S; Usui Y; Shinozaki T; Soeda S; Kawakami M; Kim H; Hanai K; Hoshi A; Nomoto T; Terachi T; Sadahiro S
Hinyokika Kiyo; 2011 Mar; 57(3):135-9. PubMed ID: 21586885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
